Pharmacy Scholarships for International Students 2026–2027

Pharmacy is one of the most valuable — and most misunderstood — degrees an international student can fund. A qualified pharmacist is a licensed healthcare professional, and pharmacy graduates are in demand in hospitals, community pharmacies, the pharmaceutical industry, regulatory agencies and research. But the degree structures differ sharply between countries, the first professional degree is long and expensive, and a pharmacy qualification does not automatically let you practise in another country. Scholarships exist at every level of pharmacy education, yet they behave very differently depending on whether you are funding a first degree (MPharm, BPharm or PharmD), a taught master’s in pharmaceutical sciences or clinical pharmacy, or a research PhD. This guide separates those three routes honestly, names the real programmes with verified amounts, and explains the licensing checks you must make before any scholarship money is worth accepting.

Start with the honest headline. Fully funded scholarships for a first professional pharmacy degree abroad are rare. Undergraduate pharmacy cohorts are small, clinical placements are costly for universities to provide, and most flagship government scholarships are postgraduate-only. What does exist for first-degree students is a layer of university merit scholarships — some genuinely substantial, such as Monash University’s Pharmacy International Merit Scholarships in Australia, which pay 50% or 25% of tuition fees for the highest-achieving commencing international students — stacked on top of family funding. At master’s level the picture transforms: Chevening, Commonwealth, DAAD, Erasmus Mundus, Fulbright, Eiffel and Australia Awards all fund pharmaceutical science, clinical pharmacy, pharmacology and related master’s degrees. At PhD level, pharmacy research is one of the better-funded areas in the life sciences, through Australia’s Research Training Program, Canada’s doctoral awards, DAAD research funding, MEXT and university studentships. This guide covers all three levels, with the amounts we verified at the time of writing in October 2026. Confirm every figure on the official page for your cycle before applying — amounts and deadlines change annually.

As you read, keep two companion resources open: our scholarships directory for the full programme list, and the Canada-specific companion to this guide, Pharmacy Scholarships in Canada for International Students 2026. University profiles such as the University of Melbourne and University of Oxford will help you compare institutions, and our rankings pages give subject context.

Pharmacy Scholarships at a Glance

Read the level column before the value column. A student who mistakes a master’s-only scheme for undergraduate funding will waste a year; a PhD applicant who overlooks RTP or CGRS-D will miss the two most systematic research-funding systems available to pharmacy researchers. The sections that follow take each level in turn, then deal with the subject that decides whether any of this money is well spent: professional registration.

First, Understand the Degree Structures

Pharmacy qualifications are not interchangeable, and scholarship eligibility follows the structure. In the United Kingdom and Ireland, the registrable first degree is the four-year (in Scotland, and at RCSI, typically four-to-five-year integrated) MPharm, accredited by the General Pharmaceutical Council (GPhC) in Great Britain or the Pharmaceutical Society of Ireland. In the United States and Canada, the first professional degree is the PharmD (Doctor of Pharmacy), a graduate-entry or direct-entry professional doctorate accredited by the ACPE in the USA and the CCAPP/AFPC framework in Canada; in Canada, note that Québec’s system and language requirements add further specifics. In Australia, the registrable route is an accredited Bachelor of Pharmacy (Honours), often combined with a Master of Pharmacy, accredited by the Australian Pharmacy Council, followed by an intern year. In much of Asia, Africa and the Middle East, the first degree is the BPharm, sometimes alongside a PharmD. Germany trains pharmacists through a state-examination (Staatsexamen) system in German — a critical point, because it means Germany’s generous funding is realistically aimed at English-taught master’s and PhD study in pharmaceutical sciences for international students, not at becoming a German community pharmacist from scratch. Japan’s pharmacist route is a six-year programme in Japanese; MEXT’s value for most international pharmacy students is likewise at research level, or undergraduate study with the required preparatory and language pathway and examinations in your country. None of this makes any route “better”; it means you must fund the degree that the regulator in the country where you intend to practise actually recognises, or a research degree whose value does not depend on registration.

Eligibility: Who Can Apply for Pharmacy Scholarships

• For first-degree (MPharm/BPharm/PharmD) scholarships: strong school-leaving results with chemistry — and usually biology and mathematics — at the level the university specifies; English proficiency at a higher bar than many degrees because of clinical placement communication (check the course page; pharmacy programmes commonly set IELTS requirements above the university minimum); and, for merit awards like Monash’s, simply being among the highest-achieving commencing students in your course group — Monash awards its Pharmacy International Merit Scholarships to commencing international students in the Bachelor of Pharmaceutical Science, Bachelor of Pharmacy (Honours), the combined Bachelor/Master of Pharmacy, the Master of Pharmaceutical Science and the Master of Global Medicines Development, with retention conditional on maintaining a weighted average mark of 70 each semester.
• For taught master’s scholarships (Chevening, Commonwealth, Eiffel, GREAT, Fulbright): a good first degree in pharmacy, pharmaceutical sciences, chemistry, biochemistry, pharmacology or a cognate life science; for Chevening, at least two years (2,800 hours) of work experience, which hospital, community, industry or regulatory pharmacy experience satisfies; for Commonwealth development framing, a plan connected to medicines access, antimicrobial resistance, pharmaceutical regulation, pharmacovigilance or public health in your home country.
• For DAAD EPOS: a bachelor’s degree normally no more than six years old, above-average results, and at least two years of relevant professional experience — and a course that appears on the current EPOS list. Pharmacy-adjacent EPOS courses in recent lists have sat in health and life-science areas; you must check the current list rather than assume a specific pharmacy course is funded.
• For research funding (RTP, CGRS-D, DAAD research, MEXT research, Commonwealth PhD): a first-class or strong upper-second honours degree or a master’s with a research component, a credible research proposal, and usually a supervisor who has agreed in principle to supervise you. For Canada’s CGRS-D, international applicants must already be enrolled in a doctoral programme at an eligible Canadian institution by the application deadline, must have completed no more than 36 months of full-time doctoral study by 31 December of the application year, and compete for up to 15% of awards reserved for international applicants; the award pays CAD 40,000 per year for 36 months. Note also that Canada’s CGRS-M master’s award is domestic-only — do not plan around it as an international applicant. The former Vanier Canada Graduate Scholarships are discontinued; CGRS-D is the replacement route.
• Registration and fitness-to-practise conditions: clinical pharmacy programmes require health checks, immunisations, criminal-record checks and fitness-to-practise declarations. A scholarship does not waive any of these.

Benefits: What Each Route Actually Pays

Fully funded master’s schemes (Chevening, Commonwealth) pay tuition in full, a monthly living stipend — Commonwealth Shared Scholarships publish £1,712 per month, or £2,000 in London, at current levels, plus airfare, a warm clothing allowance where applicable, a thesis grant and a study travel grant — and visa-related costs within their rules. Erasmus Mundus pays €1,400 per month for up to 24 months and covers participation costs for pharmaceutical-science joint masters in the current catalogue. DAAD EPOS pays €992 per month at master’s level and €1,300 per month for doctoral candidates, rising to €1,400 from February 2026, plus insurance, travel allowance and possible rent and family supplements; remember that EPOS is a stipend model and Germany’s public universities generally charge no tuition for consecutive master’s programmes, though some programmes and some states differ — and if you study in Germany without a scholarship, the visa blocked account is €11,904 for 2026. Eiffel pays €1,200 per month (master’s) or €2,100 per month (doctoral) from January 2026 plus transport, insurance and housing-search services, but explicitly does not cover tuition — pharmacy and pharmaceutical science sit within its “biology and health” field, and nomination must come from the French institution, with institutions submitting by 6 January 2027 for the 2027 campaign. Partial undergraduate awards pay percentages or fixed discounts against tuition only: Monash’s 50%/25% tuition scholarships are the standout; RCSI’s €1,500 first-year reduction shows the other end of the scale honestly — useful, but it reduces an €18,000 fee to €16,500 for one year, so your remaining budget plan matters far more than the award. Research awards combine a stipend with a tuition fee offset (RTP: base AUD 34,315 in 2026, AUD 35,550 in 2027) or a flat doctoral stipend (CGRS-D: CAD 40,000/year for 36 months). In every case, dependants, exam and registration fees, and professional-body costs are normally yours, and no scholarship in this guide pays a regulator’s overseas assessment fees.

Programmes and Specialisations You Can Fund

At taught level, the fundable pharmacy family is wider than the MPharm itself. Clinical pharmacy and pharmacy practice master’s degrees suit registered pharmacists moving into hospital and advanced practice. Pharmaceutical sciences, pharmaceutics and drug discovery suit students heading for industry R&D and formulation. Pharmacology and toxicology bridge into biomedical research. Regulatory affairs and medicines regulation — a small, employable niche — fits development and governance scholarship framing well. Pharmaceutical policy, health economics and pharmacoeconomics connect pharmacy to public health systems. Antimicrobial stewardship, pharmacovigilance and patient-safety programmes connect directly to Commonwealth and Australia Awards development themes: Australia Awards, administered by the Department of Foreign Affairs and Trade, fund study aligned with partner-country priorities — health systems and medicines access are recurring priority areas in many country programmes — and provide full tuition, return air travel, an establishment allowance, a fortnightly living contribution, health cover and academic support. At doctoral level, fundable research spans medicinal chemistry, drug delivery, clinical pharmacy services, pharmacy education, antimicrobial resistance and pharmaceutical health-services research. When comparing institutions, use our universities directory and the detailed Monash faculty information at the Monash Faculty of Pharmacy and Pharmaceutical Sciences scholarships page as an example of how a faculty presents its own awards — then replicate that search on every university on your list, because most pharmacy scholarships live on faculty pages, not university homepages.

The Licensing Warning Every Pharmacy Applicant Must Read

A scholarship pays for education; a regulator decides whether you may practise. If your goal is to register as a pharmacist in the country where you study, you generally must complete that country’s accredited first degree and its pre-registration or intern training and examinations: the GPhC route in Great Britain (MPharm plus foundation training and assessment), the Pharmacy Examining Board of Canada and provincial regulators in Canada, state boards and the NAPLEX in the USA, and the Australian Pharmacy Council-accredited degree plus intern year and registration with the Pharmacy Board of Australia. If you qualify abroad and later want to register in a different country — including returning home — expect an overseas-assessment process: for example, pharmacists with overseas qualifications seeking UK registration follow the GPhC’s Overseas Pharmacists’ Assessment Programme (OSPAP) route, a postgraduate diploma route that is itself rarely scholarship-funded. Two consequences follow. First, choose the country of your first degree by where you most plausibly will practise, not only by where a scholarship is largest. Second, if your plan is research, industry, regulation or academia rather than patient-facing practice, a master’s or PhD abroad carries no registration barrier — which is exactly why the fully funded money concentrates at postgraduate level. Verify registration rules on the regulator’s official site for your target country; university marketing pages are not the authority.

How to Apply: Step by Step

1. Fix your route first (Level 1, 2 or 3). First degree, taught master’s or research degree — the scholarship lists do not overlap, and applying across them wastes a cycle.
2. Check the regulator before the scholarship. Confirm the degree you are funding is accredited for the country where you intend to practise, or consciously choose a non-registering postgraduate route.
3. Build a two-column shortlist. Column A: flagship schemes you are eligible for by citizenship and experience (Chevening, Commonwealth, DAAD/EPOS, Erasmus Mundus, Fulbright, Eiffel, Australia Awards, MEXT). Column B: university and faculty awards at each target university (Monash-style merit awards, faculty bursaries).
4. Meet the academic and English bars early. Pharmacy English requirements are often higher than university minimums because of clinical placements; book tests through our test preparation guidance in time to retake if needed.
5. For research degrees, secure a supervisor. Email potential supervisors with a one-page proposal summary and your CV months before RTP, CGRS-D or DAAD research deadlines; applications without a supervisor’s support rarely survive.
6. Write the development or research case. Medicines access, antimicrobial resistance, counterfeit medicines, rural pharmacy services, regulatory capacity: connect your plan to a documented need in your home country for government schemes, and to a defined research question for studentships.
7. Apply to the course and the scholarship on their separate clocks. EPOS applicants apply to the listed course; Eiffel candidates must be nominated by the institution before its January submission; Chevening scholars need an unconditional offer by the scheme deadline.
8. Prepare registration and visa finances. Budget for health checks, placement checks and — if any element is self-funded — proof of funds such as Canada’s CAD 22,895 (applications 1 September 2025 to 31 August 2026) rising to CAD 23,448 from 1 September 2026, or Germany’s €11,904 blocked account (2026).

Required Documents

• Passport and identity documents
• School-leaving certificates (first degree) or degree certificates and transcripts (postgraduate), with certified translations where required
• Evidence of chemistry/biology/mathematics prerequisites where the course specifies them
• English language test results meeting the pharmacy programme’s stated requirement
• CV, including pharmacy work experience with roles, settings and dates (hospital, community, industry, regulatory)
• Personal statement or research proposal, tailored to each scheme
• Two references (academic and/or professional, per scheme rules)
• Registration certificate and good-standing evidence, if you are already a registered pharmacist applying for postgraduate study
• Health, immunisation and criminal-record documentation for clinical programmes (usually at offer/visa stage)
• Proof of funds for any self-funded element, in the format the visa authority requires

Deadlines and Timeline for 2026–2027

Selection Criteria — and How to Improve Your Chances

Pharmacy scholarship panels look for a specific combination. Quantitative academic strength: chemistry and life-science grades carry particular weight, and merit awards such as Monash’s are explicitly rank-based — the top student in each course group receives 50% tuition support and the second receives 25%, with retention tied to a weighted average mark of 70. A coherent professional story: government schemes want to see where this degree leads — a hospital clinical pharmacy service, a national pharmacovigilance centre, a medicines regulatory agency, a university department — and what you have already done in that direction. Research readiness (doctoral routes): a defined question, methods you can actually execute, any prior research exposure or publications, and a supervisor match; for CGRS-D, remember you must already be enrolled in Canada, so the real application work happens a year earlier, at admission. Honest financial planning: partial awards go further when applicants show a credible plan for the remainder; panels and visa officers both test this. And precision: pharmacy is a profession built on exactness, and sloppy applications — wrong course codes, uncertified transcripts, references that contradict your CV — are read as a professional warning sign.

Common Mistakes Pharmacy Applicants Make

• Assuming a foreign BPharm lets you practise anywhere. Registration is national. Check the regulator’s overseas route (for example the GPhC’s OSPAP in the UK) before choosing a degree.
• Applying for master’s schemes to fund an MPharm. Chevening, GREAT and Commonwealth Master’s awards fund postgraduate degrees, not first professional degrees.
• Overvaluing small discounts. A €1,500 first-year reduction (RCSI) is welcome but funds under a tenth of one year’s fee; a 50% tuition scholarship (Monash) changes the decision. Do the arithmetic per year, for the whole degree.
• Ignoring Germany’s language reality. DAAD money for international students realistically funds English-taught postgraduate pharmaceutical science; German pharmacist training itself is a German-language state-examination route.
• Planning around discontinued or domestic-only awards. Vanier Canada is discontinued — CGRS-D (CAD 40,000/year for 36 months) is the doctoral replacement — and CGRS-M is domestic-only. Destination Australia is likewise closed to new applicants (funding ceased 1 July 2024) and should never appear in a current funding plan.
• Missing that Eiffel excludes tuition. Eiffel’s stipend is generous, but tuition is not covered; confirm your fee liability with the institution.
• Forgetting placement and registration costs. Health checks, uniforms, travel to placements, professional indemnity where required and regulator fees sit outside almost every scholarship.
• Trusting agents selling “pharmacy scholarships with guaranteed admission.” No agent can award Monash merit rank, a Commonwealth nomination or a CGRS-D. Apply through official channels only.

Compare this guide with the neighbouring clinical and media fields in our guides to Dentistry Scholarships for International Students 2026–2027, Media and Communication Scholarships for International Students 2026–2027 and Medicine Scholarships for International Students 2026–2027, and plan the non-scholarship side of your application — courses, budgets and deadlines — from our study abroad hub and tools.

Frequently Asked Questions

Can I get a fully funded scholarship for an MPharm or PharmD as a first degree?

Realistically, almost never through the flagship schemes, which are postgraduate. First-degree pharmacy funding is dominated by university merit awards — Monash’s Pharmacy International Merit Scholarships (50% or 25% of tuition for the highest-achieving commencing international students) are among the strongest published examples — plus smaller discounts such as RCSI’s €1,500 first-year reduction. MEXT is a rare government exception that can fund undergraduate study in Japan, subject to its examinations and preparatory pathway.

Which scholarships fund a master’s in clinical pharmacy or pharmaceutical sciences?

Chevening and GREAT (UK), Commonwealth Master’s and Shared Scholarships (UK, development-framed courses), DAAD EPOS where a course is on the current list plus other DAAD routes (Germany), Erasmus Mundus joint masters in the current catalogue (Europe), Eiffel (France, stipend only — tuition not covered), Fulbright where your country programme funds master’s study (USA), and Australia Awards where pharmacy-related study matches your country’s priorities.

How much is the Australia RTP stipend for a pharmacy PhD?

The Australian Government’s Research Training Program base stipend is AUD 34,315 per year in 2026 and AUD 35,550 in 2027, and universities may pay above the base up to the published maximum. RTP support is normally combined with a tuition fee offset and is awarded by the university with your research-degree application, in any research field including pharmacy.

What replaced the Vanier Canada Graduate Scholarships for pharmacy PhD students?

Vanier is discontinued. The replacement doctoral award is the Canada Graduate Research Scholarship – Doctoral (CGRS-D), worth CAD 40,000 per year for 36 months across the three federal agencies (CIHR for health research, NSERC, SSHRC). International applicants are eligible for up to 15% of awards but must already be enrolled in a doctoral programme at an eligible Canadian institution by the deadline. CGRS-M, the master’s version, is domestic-only.

Will my pharmacy degree from abroad let me practise in the UK, Canada or Australia?

Not automatically. Registration is granted by each country’s regulator and normally requires that country’s accredited degree plus supervised training and examinations. Overseas-qualified pharmacists face assessment routes — for example the GPhC’s OSPAP route into UK registration — which take additional time and money and are rarely scholarship-funded. Decide where you intend to practise before choosing where to study.

Does DAAD fund pharmacy study in Germany?

DAAD funds postgraduate study and research, including pharmaceutical-science master’s and doctoral work, through EPOS (for courses on its official list: €992/month master’s; €1,300/month doctoral rising to €1,400 from February 2026) and other DAAD programmes. It does not turn an international applicant into a German pharmacist: German pharmacist qualification is a German-language state-examination degree outside the usual DAAD scholarship model.

What grades do I need for pharmacy scholarships?

For merit awards, you need to be at or near the top of the commencing cohort (Monash’s awards are explicitly rank-based and require you to maintain a weighted average mark of 70). For flagship master’s schemes, expect a strong first degree — typically first-class or upper-second equivalence — plus, for Chevening and EPOS, at least two years of documented relevant work or professional experience.

Are there pharmacy scholarships in Canada specifically?

Yes, but they are structured differently: university entrance and faculty awards for PharmD and BScPharm students, plus CGRS-D at doctoral level once you are enrolled. Our companion guide, Pharmacy Scholarships in Canada for International Students 2026, covers the Canadian system in detail, including study-permit proof of funds (CAD 22,895 for applications from 1 September 2025 to 31 August 2026; CAD 23,448 from 1 September 2026).

Sources & Verification

Key facts were checked in October 2026 against: the Monash Faculty of Pharmacy and Pharmaceutical Sciences scholarships page and Monash scholarship terms (Pharmacy International Merit Scholarships: 50% / 25% of tuition, retention at weighted average mark 70); the RCSI International Pharmacy and Biomolecular Sciences Scholarship (€1,500 first-year tuition reduction, €18,000 to €16,500); Chevening — scholarship coverage; Commonwealth Scholarship Commission — Shared Scholarships (stipend £1,712/month, £2,000 London, full tuition and airfare); DAAD EPOS programme information via daad.de/epos (€992/month; doctoral €1,300 rising to €1,400 from February 2026; experience and course-list rules); Campus France Eiffel information (€1,200/€2,100 per month from January 2026, tuition not covered, institutional submission 6 January 2027, biology and health eligible); the Australian Department of Education — Research Training Program (AUD 34,315 in 2026; AUD 35,550 in 2027); Australia Awards benefit descriptions via Australian Government Australia Awards pages; the NSERC Canada Graduate Research Scholarship – Doctoral program (CAD 40,000/year, 36 months, 17 October agency deadline, international enrolment condition); and British Council Study UK — GREAT Scholarships (£10,000 towards tuition). Verified standing facts applied: Canada study-permit living funds CAD 22,895 / CAD 23,448 from 1 September 2026; Germany blocked account €11,904 (2026); Destination Australia closed (funding ceased 1 July 2024); Vanier discontinued, replaced by CGRS-D.

Disclaimer: Scholarship amounts, eligible countries, course lists and deadlines change every cycle, and professional registration rules are set by national regulators, not universities. Always confirm details on the official scholarship and regulator websites before applying. StudyGraduate is an information portal, not an agency: we never promise or guarantee selection, admission, registration or visa approval.